Skip to main content

Table 1 Study visit schedule

From: A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial

  Baseline SPC within 3 weeks 4 weeks 8 weeks 12 weeks 16 weeks 20 weeks 24 weeks Monthly SPC until Death/EOT 24 weeks after death
Intervention           
Patient QLQC-30, LC13, EQ-5D, GHQ-12 X     X    X   
SPC review   X X X X X X X X  
Telephone interview (QLQC-30, LC13)    X X   X X    
Carer GHQ-12, SF-36, FAMCARE-2 X     X    X   X
Control           
Patient QLQC-30, LC13, EQ-5D, GHQ-12 X     X    X   
Telephone interview (QLQC-30, LC13)    X X   X X    
Carer GHQ-12, SF-36, FAMCARE-2 X     X    X   X
  1. EOT = end of trial;EQ-5D = EuroQol-5D;FAMCARE-2 = family satisfaction with advanced cancer care 2; GHQ-12 = General Health Questionnaire-12; LC13 = lung cancer supplement;,QLQ-C30 = Quality of Life Questionnaire Core 30;SF-36 = Short Form 36;SPC = Specialist Palliative Care.